{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:28:40Z","timestamp":1783391320972,"version":"3.54.6"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1245\/s10434-025-18474-4","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:17:25Z","timestamp":1760530645000},"page":"1162-1170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Systematic Review of Occult Malignancy and Sentinel Lymph Node Metastasis at the Time of Contralateral Prophylactic Mastectomy"],"prefix":"10.1245","volume":"33","author":[{"given":"Jenna L.","family":"Sturz-Ellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney N.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3820-3228","authenticated-orcid":false,"given":"Judy C.","family":"Boughey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"18474_CR1","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1245\/s10434-016-5688-z","volume":"24","author":"KK Hunt","year":"2017","unstructured":"Hunt KK, Euhus DM, Boughey JC, et al. Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy. Ann Surg Oncol. 2017;24:375\u201397. https:\/\/doi.org\/10.1245\/s10434-016-5688-z.","journal-title":"Ann Surg Oncol."},{"key":"18474_CR2","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s10434-999-0542-1","volume":"6","author":"LL Montgomery","year":"1999","unstructured":"Montgomery LL, Tran KN, Heelan MC, et al. Issues of regret in women with contralateral prophylactic mastectomies. Ann Surg Oncol. 1999;6:546\u201352. https:\/\/doi.org\/10.1007\/s10434-999-0542-1.","journal-title":"Ann Surg Oncol."},{"key":"18474_CR3","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1148\/radiol.2263020041","volume":"226","author":"SG Lee","year":"2003","unstructured":"Lee SG, Orel SG, Woo IJ, et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology. 2003;226:773\u20138. https:\/\/doi.org\/10.1148\/radiol.2263020041. (Epub 31 January 2003).","journal-title":"Radiology."},{"key":"18474_CR4","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1245\/s10434-012-2299-1","volume":"19","author":"A Chung","year":"2012","unstructured":"Chung A, Huynh K, Lawrence C, Sim MS, Giuliano A. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients. Ann Surg Oncol. 2012;19:2600\u20136. https:\/\/doi.org\/10.1245\/s10434-012-2299-1. (Epub 7 March 2012).","journal-title":"Ann Surg Oncol."},{"key":"18474_CR5","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1245\/s10434-016-5408-8","volume":"23","author":"JC Boughey","year":"2016","unstructured":"Boughey JC, Attai DJ, Chen SL, et al. Contralateral Prophylactic Mastectomy Consensus Statement from the American Society of Breast Surgeons: Additional Considerations and a Framework for Shared Decision Making. Ann Surg Oncol. 2016;23:3106\u201311. https:\/\/doi.org\/10.1245\/s10434-016-5408-8. (Epub 28 July 2016).","journal-title":"Ann Surg Oncol."},{"key":"18474_CR6","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1245\/s10434-024-14893-x","volume":"31","author":"P Singh","year":"2024","unstructured":"Singh P, Agnese D, Amin M, et al. Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks. Ann Surg Oncol. 2024;31:2212\u201323. https:\/\/doi.org\/10.1245\/s10434-024-14893-x. (Epub 23 January 2024).","journal-title":"Ann Surg Oncol."},{"key":"18474_CR7","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1056\/NEJMoa2412063","volume":"392","author":"T Reimer","year":"2025","unstructured":"Reimer T, Stachs A, Veselinovic K, et al. Axillary surgery in breast cancer: primary results of the INSEMA trial. N Engl J Med. 2025;392:1051\u201364. https:\/\/doi.org\/10.1056\/NEJMoa2412063. (Epub 12 December 2024).","journal-title":"N Engl J Med."},{"key":"18474_CR8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jamcollsurg.2008.06.139","volume":"207","author":"A Karam","year":"2008","unstructured":"Karam A, Stempel M, Cody HS III, Port ER. Reoperative sentinel lymph node biopsy after previous mastectomy. J Am Coll Surg. 2008;207:543\u20138. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2008.06.139. (Epub 21 July 2008).","journal-title":"J Am Coll Surg."},{"key":"18474_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ."},{"key":"18474_CR10","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1245\/s10434-016-5367-0","volume":"23","author":"BL Murphy","year":"2016","unstructured":"Murphy BL, Hoskin TL, Boughey JC, Degnim AC, Glazebrook KN, Hieken TJ. Contralateral prophylactic mastectomy for women with T4 locally advanced breast cancer. Ann Surg Oncol. 2016;23:3365\u201370. https:\/\/doi.org\/10.1245\/s10434-016-5367-0. (Epub 30 June 2016).","journal-title":"Ann Surg Oncol."},{"key":"18474_CR11","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1245\/s10434-017-5925-0","volume":"24","author":"BL Murphy","year":"2017","unstructured":"Murphy BL, Glasgow AE, Keeney GL, Habermann EB, Boughey JC. Selective use of sentinel lymph node surgery in patients undergoing prophylactic mastectomy using intraoperative pathology. Ann Surg Oncol. 2017;24:3032\u20137. https:\/\/doi.org\/10.1245\/s10434-017-5925-0. (Epub 1 August 2017).","journal-title":"Ann Surg Oncol."},{"key":"18474_CR12","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.1245\/s10434-022-11916-3","volume":"29","author":"SM Wong","year":"2022","unstructured":"Wong SM, Ferroum A, Apostolova C, et al. Incidence of occult breast cancer in carriers of BRCA1\/2 or other high-penetrance pathogenic variants undergoing prophylactic mastectomy: when is sentinel lymph node biopsy indicated? Ann Surg Oncol. 2022;29:6660\u20138. https:\/\/doi.org\/10.1245\/s10434-022-11916-3. (Epub 26 May 2022).","journal-title":"Ann Surg Oncol."},{"key":"18474_CR13","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/cncr.22176","volume":"107","author":"JC Boughey","year":"2006","unstructured":"Boughey JC, Khakpour N, Meric-Bernstam F, et al. Selective use of sentinel lymph node surgery during prophylactic mastectomy. Cancer. 2006;107:1440\u20137. https:\/\/doi.org\/10.1002\/cncr.22176.","journal-title":"Cancer."},{"key":"18474_CR14","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/MAJ.0b013e31824a82ce","volume":"344","author":"PN Barry","year":"2012","unstructured":"Barry PN, Johnson RR, Harkenrider MM, et al. Contralateral prophylactic mastectomy: clinical and pathological features from a prospective database. Am J Med Sci. 2012;344:452\u20136. https:\/\/doi.org\/10.1097\/MAJ.0b013e31824a82ce.","journal-title":"Am J Med Sci."},{"key":"18474_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jss.2010.07.020","volume":"164","author":"SM Nasser","year":"2010","unstructured":"Nasser SM, Smith SG, Chagpar AB. The role of sentinel node biopsy in women undergoing prophylactic mastectomy. J Surg Res. 2010;164:188\u201392. https:\/\/doi.org\/10.1016\/j.jss.2010.07.020. (Epub 6 August 2010).","journal-title":"J Surg Res."},{"key":"18474_CR16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1245\/s10434-014-3883-38","volume":"22","author":"K Yao","year":"2015","unstructured":"Yao K, Liederbach E, Tang R, et al. Nipple-sparing mastectomy in BRCA1\/2 mutation carriers: an interim analysis and review of the literature. Ann Surg Oncol. 2015;22:370\u20136. https:\/\/doi.org\/10.1245\/s10434-014-3883-38. (Epub 15 July 2014).","journal-title":"Ann Surg Oncol."},{"key":"18474_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/s0002-9610(00)00458-x","volume":"180","author":"EL Dupont","year":"2000","unstructured":"Dupont EL, Kuhn MA, McCann C, Salud C, Spanton JL, Cox CE. The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy. Am J Surg. 2000;180:274\u20137. https:\/\/doi.org\/10.1016\/s0002-9610(00)00458-x.","journal-title":"Am J Surg."},{"key":"18474_CR18","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.cireng.2021.10.008","volume":"99","author":"M Domingo Bret\u00f3n","year":"2021","unstructured":"Domingo Bret\u00f3n M, Allu\u00e9 Caba\u00f1uz M, Cast\u00e1n Villanueva N, Arribas Del Amo MD, Gil Romea I, G\u00fcemes S\u00e1nchez A. CBCRisk model to determine the risk of contralateral breast cancer in sporadic breast cancer. Cir Esp (Engl Ed). 2021;99:724\u20139. https:\/\/doi.org\/10.1016\/j.cireng.2021.10.008. (Epub 8 November 2021).","journal-title":"Cir Esp (Engl Ed)."},{"key":"18474_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/PRS.0000000000005690","volume":"144","author":"B Alba","year":"2019","unstructured":"Alba B, Schultz BD, Cohen D, Qin AL, Chan W, Tanna N. Risk-to-benefit relationship of contralateral prophylactic mastectomy: the argument for bilateral mastectomies with immediate reconstruction. Plast Reconstr Surg. 2019;144:1\u20139. https:\/\/doi.org\/10.1097\/PRS.0000000000005690.","journal-title":"Plast Reconstr Surg."},{"key":"18474_CR20","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/jso.23575","volume":"109","author":"PW Bunting","year":"2014","unstructured":"Bunting PW, Cyr AE, Gao F, Margenthaler JA. Sentinel lymph node biopsy during prophylactic mastectomy: is there a role? J Surg Oncol. 2014;109:747\u201350. https:\/\/doi.org\/10.1002\/jso.23575. (Epub 17 February 2014).","journal-title":"J Surg Oncol."},{"key":"18474_CR21","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/cncr.23298","volume":"112","author":"SA McLaughlin","year":"2008","unstructured":"McLaughlin SA, Stempel M, Morris EA, Liberman L, King TA. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy? Cancer. 2008;112:1214\u201321. https:\/\/doi.org\/10.1002\/cncr.23298.","journal-title":"Cancer."},{"key":"18474_CR22","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1245\/s10434-007-9356-1","volume":"14","author":"D Black","year":"2007","unstructured":"Black D, Specht M, Lee JM, et al. Detecting occult malignancy in prophylactic mastectomy: preoperative MRI versus sentinel lymph node biopsy. Ann Surg Oncol. 2007;14:2477\u201384. https:\/\/doi.org\/10.1245\/s10434-007-9356-1. (Epub 22 June 2007).","journal-title":"Ann Surg Oncol."},{"key":"18474_CR23","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1503\/cjs.006010","volume":"54","author":"W-B Zhou","year":"2011","unstructured":"Zhou W-B, Liu X-A, Dai J-C, Wang S. Meta-analysis of sentinel lymph node biopsy at the time of prophylactic mastectomy of the breast. Can J Surg. 2011;54:300\u20136. https:\/\/doi.org\/10.1503\/cjs.006010.","journal-title":"Can J Surg."},{"key":"18474_CR24","doi-asserted-by":"publisher","first-page":"E298","DOI":"10.1503\/cjs.001922","volume":"66","author":"L Cadili","year":"2023","unstructured":"Cadili L, Pao J-S, McKevitt E, Dingee C, Bazzarelli A, Warburton R. Nipple margin assessment at the time of nipple-sparing mastectomy. Can J Surg. 2023;66:E298\u2013303. https:\/\/doi.org\/10.1503\/cjs.001922.","journal-title":"Can J Surg."},{"key":"18474_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1001\/jamasurg.2017.3422","volume":"153","author":"JW Jakub","year":"2018","unstructured":"Jakub JW, Peled AW, Gray RJ, et al. Oncologic safety of prophylactic nipple-sparing mastectomy in a population with BRCA mutations: a multi-institutional study. JAMA Surg. 2018;153:123\u20139. https:\/\/doi.org\/10.1001\/jamasurg.2017.3422.","journal-title":"JAMA Surg."},{"key":"18474_CR26","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/SLA.0b013e3181c3c36d","volume":"251","author":"R Kaas","year":"2010","unstructured":"Kaas R, Verhoef S, Wesseling J, et al. Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: very low risk for subsequent breast cancer. Ann Surg. 2010;251:488\u201392. https:\/\/doi.org\/10.1097\/SLA.0b013e3181c3c36d.","journal-title":"Ann Surg."},{"key":"18474_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.breast.2013.10.008","volume":"23","author":"Y Sim","year":"2014","unstructured":"Sim Y, Tan VKM, Ho GH, et al. Contralateral prophylactic mastectomy in an Asian population: a single-institution review. Breast. 2014;23:56\u201362. https:\/\/doi.org\/10.1016\/j.breast.2013.10.008. (Epub 23 Nov 2013).","journal-title":"Breast."},{"key":"18474_CR28","doi-asserted-by":"publisher","unstructured":"Schrenk P, W\u00f6lfl S, Bogner S, Huemer GM, Wayand W. Symmetrization reduction mammaplasty combined with sentinel node biopsy in patients operated for contralateral breast cancer. J Surg Oncol. 2006;94:437. Huemer, Georg [corrected to Huemer, Georg M].\u00a0J Surg Oncol. 2006;94:9\u201315. https:\/\/doi.org\/10.1002\/jso.20542.","DOI":"10.1002\/jso.20542"},{"key":"18474_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10549-013-2583-1","volume":"140","author":"DGR Evans","year":"2013","unstructured":"Evans DGR, Ingham SL, Baildam A, et al. Contralateral mastectomy improves survival in women with BRCA1\/2-associated breast cancer. Breast Cancer Res Treat. 2013;140:135\u201342. https:\/\/doi.org\/10.1007\/s10549-013-2583-1. (Epub 20 June 2013).","journal-title":"Breast Cancer Res Treat."},{"key":"18474_CR30","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1002\/cncr.20617","volume":"101","author":"K Goldflam","year":"2004","unstructured":"Goldflam K, Hunt KK, Gershenwald JE, et al. Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer. 2004;101:1977\u201386. https:\/\/doi.org\/10.1002\/cncr.20617.","journal-title":"Cancer."},{"key":"18474_CR31","doi-asserted-by":"publisher","first-page":"378","DOI":"10.5858\/2000-124-0378-PMPFIH","volume":"124","author":"KK Khurana","year":"2000","unstructured":"Khurana KK, Loosmann A, Numann PJ, Khan SA. Prophylactic mastectomy: pathologic findings in high-risk patients. Arch Pathol Lab Med. 2000;124:378\u201381. https:\/\/doi.org\/10.5858\/2000-124-0378-PMPFIH.","journal-title":"Arch Pathol Lab Med."},{"key":"18474_CR32","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.jamcollsurg.2009.08.010","volume":"209","author":"C Laronga","year":"2009","unstructured":"Laronga C, Lee MC, McGuire KP, et al. Indications for sentinel lymph node biopsy in the setting of prophylactic mastectomy. J Am Coll Surg. 2009;209:746\u201352. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2009.08.010. (Epub 17 October 2009).","journal-title":"J Am Coll Surg."},{"key":"18474_CR33","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1245\/s10434-012-2299-1","volume":"19","author":"A Chung","year":"2012","unstructured":"Chung A, Huynh K, Lawrence C, Sim M-S, Giuliano A. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients. Ann Surg Oncol. 2012;19:2600\u20136. https:\/\/doi.org\/10.1245\/s10434-012-2299-1. (Epub 7 March 2012).","journal-title":"Ann Surg Oncol."},{"key":"18474_CR34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/SLA.0b013e3182125b26","volume":"254","author":"TA King","year":"2011","unstructured":"King TA, Gurevich I, Sakr R, Patil S, Stempel M, Morrow M. Occult malignancy in patients undergoing contralateral prophylactic mastectomy. Ann Surg. 2011;254:2\u20137. https:\/\/doi.org\/10.1097\/SLA.0b013e3182125b26.","journal-title":"Ann Surg."},{"key":"18474_CR35","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1148\/radiol.2263020041","volume":"226","author":"SG Lee","year":"2003","unstructured":"Lee SG, Orel SG, Woo IJ, et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology. 2003;226:773\u20138. https:\/\/doi.org\/10.1148\/radiol.2263020041. (Epub 31 January 2003).","journal-title":"Radiology."},{"key":"18474_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jamcollsurg.2007.01.064","volume":"205","author":"A Soran","year":"2007","unstructured":"Soran A, Falk J, Bonaventura M, Keenan D, Ahrendt G, Johnson R. Does failure to visualize a sentinel node on preoperative lymphoscintigraphy predict a greater likelihood of axillary lymph node positivity? J Am Coll Surg. 2007;205:66\u201371. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2007.01.064.","journal-title":"J Am Coll Surg."},{"key":"18474_CR37","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/cncr.24129","volume":"115","author":"M Yi","year":"2009","unstructured":"Yi M, Meric-Bernstam F, Middleton LP, et al. Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy. Cancer. 2009;115:962\u201371. https:\/\/doi.org\/10.1002\/cncr.24129.","journal-title":"Cancer."},{"key":"18474_CR38","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/jso.23018","volume":"105","author":"IA Czyszczon","year":"2012","unstructured":"Czyszczon IA, Roland L, Sahoo S. Routine prophylactic sentinel lymph node biopsy is not indicated in women undergoing prophylactic mastectomy. J Surg Oncol. 2012;105:650\u20134. https:\/\/doi.org\/10.1002\/jso.23018. (Epub 27 December 2011).","journal-title":"J Surg Oncol."},{"key":"18474_CR39","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/cam4.663","volume":"5","author":"V Freitas","year":"2016","unstructured":"Freitas V, Crystal P, Kulkarni S, et al. The value of breast MRI in high-risk patients with newly diagnosed breast cancer to exclude invasive disease in the contralateral prophylactic mastectomy: Is there a role to choose wisely patients for sentinel node biopsy? Cancer Med. 2016;5:1031\u20136. https:\/\/doi.org\/10.1002\/cam4.663. (Epub 18 March 2016).","journal-title":"Cancer Med."},{"key":"18474_CR40","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1245\/s10434-015-4896-2","volume":"23","author":"D Mattos","year":"2016","unstructured":"Mattos D, Gfrerer L, Ling ITC, et al. Occult histopathology and its predictors in contralateral and bilateral prophylactic mastectomies. Ann Surg Oncol. 2016;23:767\u201375. https:\/\/doi.org\/10.1245\/s10434-015-4896-2. (Epub 17 November 2015).","journal-title":"Ann Surg Oncol."},{"key":"18474_CR41","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1245\/s10434-012-2299-1","volume":"19","author":"A Chung","year":"2012","unstructured":"Chung A, Huynh K, Lawrence C, Sim M-S, Giuliano A. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients. Ann Surg Oncol. 2012;19:2600\u20136. https:\/\/doi.org\/10.1245\/s10434-012-2299-1. (Epub 7 March 2012).","journal-title":"Ann Surg Oncol."},{"key":"18474_CR42","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/tbj.12157","volume":"19","author":"A Burger","year":"2013","unstructured":"Burger A, Thurtle D, Owen S, et al. Sentinel lymph node biopsy for risk-reducing mastectomy. Breast J. 2013;19:529\u201332. https:\/\/doi.org\/10.1111\/tbj.12157. (Epub 19 July 2013).","journal-title":"Breast J."},{"key":"18474_CR43","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.1245\/s10434-022-11916-3","volume":"29","author":"SM Wong","year":"2022","unstructured":"Wong SM, Ferroum A, Apostolova C, et al. Incidence of occult breast cancer in carriers of BRCA1\/2 or other high-penetrance pathogenic variants undergoing prophylactic mastectomy: When is sentinel lymph node biopsy indicated? Ann Surg Oncol. 2022;29:6660\u20138. https:\/\/doi.org\/10.1245\/s10434-022-11916-3. (Epub 26 May 2022).","journal-title":"Ann Surg Oncol."},{"key":"18474_CR44","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.clbc.2013.02.006","volume":"13","author":"NK Kuwajerwala","year":"2013","unstructured":"Kuwajerwala NK, Dekhne NS, Pentiak PA, et al. Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital. Clin Breast Cancer. 2013;13:287\u201391. https:\/\/doi.org\/10.1016\/j.clbc.2013.02.006. (Epub 23 May 2013).","journal-title":"Clin Breast Cancer."},{"key":"18474_CR45","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/tbj.13512","volume":"26","author":"A Nomikos","year":"2020","unstructured":"Nomikos A, Husain EA, Graham AD. Occult disease in reduction mammoplasties and prophylactic mastectomies. Breast J. 2020;26:691\u20136. https:\/\/doi.org\/10.1111\/tbj.13512. (Epub 25 August 2019).","journal-title":"Breast J."},{"key":"18474_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4048\/jbc.2024.0219","volume":"28","author":"CE Lee","year":"2025","unstructured":"Lee CE, Shin DS, Kim KJ, et al. The incidence of occult malignancy in contralateral risk reducing mastectomy among affected breast cancer gene mutation carriers in South Korea. J Breast Cancer. 2025;28:1\u201310. https:\/\/doi.org\/10.4048\/jbc.2024.0219.","journal-title":"J Breast Cancer."},{"key":"18474_CR47","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1245\/s10434-015-4660-7","volume":"23","author":"LM Erdahl","year":"2016","unstructured":"Erdahl LM, Boughey JC, Hoskin TL, Degnim AC, Hieken TJ. Contralateral prophylactic mastectomy: Factors predictive of occult malignancy or high-risk lesion and the impact of MRI and genetic testing. Ann Surg Oncol. 2016;23:72\u20137. https:\/\/doi.org\/10.1245\/s10434-015-4660-7. (Epub 12 June 2015).","journal-title":"Ann Surg Oncol."},{"key":"18474_CR48","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.clbc.2012.12.001","volume":"13","author":"V Murthy","year":"2013","unstructured":"Murthy V, Chamberlain RS. Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy? Clin Breast Cancer. 2013;13:180\u20137. https:\/\/doi.org\/10.1016\/j.clbc.2012.12.001. (Epub 26 January 2013).","journal-title":"Clin Breast Cancer."},{"key":"18474_CR49","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1245\/s10434-014-3852-x","volume":"21","author":"C Xia","year":"2014","unstructured":"Xia C, Schroeder MC, Weigel RJ, Sugg SL, Thomas A. Rate of contralateral prophylactic mastectomy is influenced by preoperative MRI recommendations. Ann Surg Oncol. 2014;21:4133\u20138. https:\/\/doi.org\/10.1245\/s10434-014-3852-x. (Epub 17 June 2014).","journal-title":"Ann Surg Oncol."},{"key":"18474_CR50","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10549-018-4953-1","volume":"172","author":"H Yamauchi","year":"2018","unstructured":"Yamauchi H, Okawa M, Yokoyama S, et al. High rate of occult cancer found in prophylactic mastectomy specimens despite thorough presurgical assessment with MRI and ultrasound: findings from the hereditary breast and ovarian cancer registration 2016 in Japan. Breast Cancer Res Treat. 2018;172:679\u201387. https:\/\/doi.org\/10.1007\/s10549-018-4953-1. (Epub 10 September 2018).","journal-title":"Breast Cancer Res Treat."},{"key":"18474_CR51","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.amjsurg.2021.03.040","volume":"221","author":"H Kapur","year":"2021","unstructured":"Kapur H, Warburton R, Pao J-S, Dingee C, Chen L, McKevitt E. Decreasing contralateral prophylactic mastectomy rates in average-risk women with unilateral breast cancer. Am J Surg. 2021;221:1172\u20136. https:\/\/doi.org\/10.1016\/j.amjsurg.2021.03.040.","journal-title":"Am J Surg."},{"key":"18474_CR52","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.clbc.2022.12.003","volume":"23","author":"V Madan","year":"2023","unstructured":"Madan V, Mamounas EP. Is sentinel lymph node biopsy necessary in patients who undergo prophylactic mastectomy? Clin Breast Cancer. 2023;23:231\u20136. https:\/\/doi.org\/10.1016\/j.clbc.2022.12.003. (Epub 8 December 2022).","journal-title":"Clin Breast Cancer."},{"key":"18474_CR53","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s12282-018-0850-z","volume":"25","author":"A Yoshimura","year":"2018","unstructured":"Yoshimura A, Okumura S, Sawaki M, et al. Feasibility study of contralateral risk-reducing mastectomy with breast reconstruction for breast cancer patients with BRCA mutations in Japan. Breast Cancer. 2018;25:539\u201346. https:\/\/doi.org\/10.1007\/s12282-018-0850-z. (Epub 8 December 2018).","journal-title":"Breast Cancer."},{"key":"18474_CR54","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/jso.27088","volume":"127","author":"JL Thompson","year":"2023","unstructured":"Thompson JL, Sinco BR, McCaffrey RL, et al. Prophylactic mastectomy and occult malignancy: Surgical and imaging considerations. J Surg Oncol. 2023;127:18\u201327. https:\/\/doi.org\/10.1002\/jso.27088. (Epub 7 September 2022).","journal-title":"J Surg Oncol."},{"key":"18474_CR55","doi-asserted-by":"publisher","first-page":"117822342413110","DOI":"10.1177\/11782234241311018","volume":"19","author":"M Mooghal","year":"2025","unstructured":"Mooghal M, Khan W, Anjum S, Shaikh H, Virji SN, Vohra LM. Occult breast cancer in high-risk gene-positive Pakistani women undergoing contralateral prophylactic mastectomy\/prophylactic mastectomy: Implications for sentinel lymph node biopsy. Breast Cancer (Auckl). 2025;19:11782234241311018. https:\/\/doi.org\/10.1177\/11782234241311018. (eCollection 2025).","journal-title":"Breast Cancer (Auckl)."},{"key":"18474_CR56","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1503\/cjs.006010.PMID:21651834;PMCID:PMC3195666","volume":"54","author":"W-B Zhou","year":"2011","unstructured":"Zhou W-B, Liu X-A, Dai J-C, Wang S. Meta-analysis of sentinel lymph node biopsy at the time of prophylactic mastectomy of the breast. Can J Surg. 2011;54:300\u20136. https:\/\/doi.org\/10.1503\/cjs.006010.PMID:21651834;PMCID:PMC3195666.","journal-title":"Can J Surg."},{"key":"18474_CR57","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1148\/radiol.10091881","volume":"256","author":"LE Ichikawa","year":"2010","unstructured":"Ichikawa LE, Barlow WE, Anderson ML, et al. Time trends in radiologists\u2019 interpretive performance at screening mammography from the community-based Breast Cancer Surveillance Consortium, 1996\u20132004. Radiology. 2010;256:74\u201382. https:\/\/doi.org\/10.1148\/radiol.10091881. (Epub 26 May 2010).","journal-title":"Radiology."},{"key":"18474_CR58","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1002\/cam4.1036","volume":"6","author":"CR Clark","year":"2017","unstructured":"Clark CR, Tosteson TD, Tosteson ANA, et al. Diffusion of digital breast tomosynthesis among women in primary care: associations with insurance type. Cancer Med. 2017;6:1102\u20137. https:\/\/doi.org\/10.1002\/cam4.1036. (Epub 4 April 2017).","journal-title":"Cancer Med."},{"key":"18474_CR59","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1200\/OP.22.00578","volume":"19","author":"I-W Pan","year":"2023","unstructured":"Pan I-W, Yen TWF, Bedrosian I, Shih Y-CT. Current trends in the utilization of preoperative breast magnetic resonance imaging among women with newly diagnosed breast cancer. JCO Oncol Pract. 2023;19:446\u201355. https:\/\/doi.org\/10.1200\/OP.22.00578. (Epub 17 April 2023).","journal-title":"JCO Oncol Pract."},{"key":"18474_CR60","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ejso.2009.09.007","volume":"36","author":"J de Bresser","year":"2010","unstructured":"de Bresser J, de Vos B, van der Ent F, Hulsew\u00e9 K. Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review. Eur J Surg Oncol. 2010;36:114\u20139. https:\/\/doi.org\/10.1016\/j.ejso.2009.09.007. (Epub 12 October 2009).","journal-title":"Eur J Surg Oncol."},{"key":"18474_CR61","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s10238-025-01591-5","volume":"25","author":"Q Li","year":"2025","unstructured":"Li Q, Xu H, Bao B, et al. Predicting sentinel lymph node metastasis in breast cancer: a study based on the SEER database. Clin Exp Med. 2025;25:82. https:\/\/doi.org\/10.1007\/s10238-025-01591-5.","journal-title":"Clin Exp Med."},{"key":"18474_CR62","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jamaoncol.2023.3759","volume":"9","author":"OD Gentilini","year":"2023","unstructured":"Gentilini OD, Botteri E, Sangalli C, et al. Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial. JAMA Oncol. 2023;9:1557\u201364. https:\/\/doi.org\/10.1001\/jamaoncol.2023.3759.","journal-title":"JAMA Oncol."},{"key":"18474_CR63","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/bjs\/znad215","volume":"110","author":"C Tinterri","year":"2023","unstructured":"Tinterri C, Canavese G, Gatzemeier W, et al. Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment. Br J Surg. 2023;110:1143\u201352. https:\/\/doi.org\/10.1093\/bjs\/znad215.","journal-title":"Br J Surg."},{"key":"18474_CR64","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1245\/s10434-016-5558-8","volume":"24","author":"A Recht","year":"2017","unstructured":"Recht A, Comen EA, Fine RE, et al. Postmastectomy radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology focused guideline update. Ann Surg Oncol. 2017;24:38\u201351. https:\/\/doi.org\/10.1245\/s10434-016-5558-8. (Epub 19 September 2016).","journal-title":"Ann Surg Oncol."},{"key":"18474_CR65","doi-asserted-by":"crossref","unstructured":"Kunkler, I. Does postmastectomy radiotherapy in \u201cintermediate-risk\u201d breast cancer impact overall survival? 10 Year results of the BIG 2-04 MRC SUPREMO randomised trial: on behalf of the SUPREMO trial investigators [abstract]. In: Proceedings of the San Antonio Breast Cancer Symposium 2024, 10\u201313 December 2024, San Antonio, TX. Philadelphia, PA: AACR. Clin Cancer Res. 2025;31(12 Suppl):abstract nr SESS-3537.","DOI":"10.1158\/1557-3265.SABCS24-GS2-03"},{"key":"18474_CR66","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1056\/NEJMoa065447","volume":"356","author":"CD Lehman","year":"2007","unstructured":"Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356:1295\u2013303. https:\/\/doi.org\/10.1056\/NEJMoa065447. (Epub 28 March 2007).","journal-title":"N Engl J Med."},{"key":"18474_CR67","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1245\/s10434-007-9356-1","volume":"14","author":"D Black","year":"2007","unstructured":"Black D, Specht M, Lee JM, et al. Detecting occult malignancy in prophylactic mastectomy: preoperative MRI versus sentinel lymph node biopsy. Ann Surg Oncol. 2007;14:2477\u201384. https:\/\/doi.org\/10.1245\/s10434-007-9356-1. (Epub 22 June 2007).","journal-title":"Ann Surg Oncol."},{"key":"18474_CR68","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1245\/s10434-022-13064-0","volume":"30","author":"A Karakatsanis","year":"2023","unstructured":"Karakatsanis A, Eriksson S, Pistiolis L, et al. Delayed sentinel lymph node dissection in patients with a preoperative diagnosis of ductal cancer in situ by preoperative injection with superparamagnetic iron oxide (SPIO) nanoparticles: The SentiNot Study. Ann Surg Oncol. 2023;30:4064\u201372. https:\/\/doi.org\/10.1245\/s10434-022-13064-0. (Epub 31 January 2023).","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18474-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18474-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18474-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:33:33Z","timestamp":1767573213000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18474-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["18474"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18474-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Judy Boughey had research funding paid to her institution from Eli Lilly, SimBioSys, and Quantum Leap Healthcare. She also sits on the DSMB for Cairn Surgical.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}